🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
To evaluate the clinical mechanisms of action in lung and extrapulmonary sy...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02508207
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
This is a Phase 2, randomized, double blind, placebo and active-controlled,...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02951195
The objective of this study was to evaluate the safety and efficacy of VX-6...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02070744
Treatments Being Tested
People with Cystic Fibrosis (CF) have problems digesting their food properl...
Status
Completed
Location
Nottingham University Hospitals NHS Trust
Start Date
2019-09-03
Trial ID
NCT04006873
Treatments Being Tested
The primary purpose of study is to evaluate the treatment effect of tezacaf...
Status
Completed
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT02730208
Treatments Being Tested
The purpose of the study is to evaluate safety, tolerability, and pharmacok...
Status
Completed
Location
Joe DiMaggio Cycstic Fibrosis & Pulmonary Center
Start Date
2023-12-12
Trial ID
NCT06154447
Treatments Being Tested
This study will evaluate the efficacy of tezacaftor in combination with iva...
Status
Completed
Location
Hunter Medical Research Institute (HMRI)
Start Date
2018-05-17
Trial ID
NCT03559062
Study to evaluate the efficacy of VX-661 in combination with ivacaftor (IVA...
Status
Completed
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02516410